• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受生物人工主动脉瓣植入的患者中,患者-人工瓣膜不匹配会增加因人工瓣膜结构退化而再次手术的风险。

Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.

作者信息

Urso Stefano, Calderón Pilar, Sadaba Rafael, Mahillo Ignacio, Tuñón José, Aldamiz Gonzalo, Fraile Julián

机构信息

Department of Cardiac Surgery, Hospital Dr.Negrín, Las Palmas de Gran Canaria, Spain.

出版信息

J Card Surg. 2014 Jul;29(4):439-44. doi: 10.1111/jocs.12345. Epub 2014 Apr 29.

DOI:10.1111/jocs.12345
PMID:24773571
Abstract

OBJECTIVES

Patient-prosthesis mismatch has been identified as a risk factor for mortality after aortic valve replacement and for structural valve deterioration (SVD) in patients receiving a bioprosthetic aortic valve. The aim of the present study was to compare the incidence of aortic valve bioprosthesis replacement for SVD in patients with mismatch to a population without mismatch.

METHODS

Three hundred eighty-seven adult patients who underwent aortic valve replacement with a bioprosthesis from 1974 to 2009 were retrospectively reviewed. Mismatch was considered to be present if the anticipated indexed effective orifice area was <0.70 cm(2) /m(2) . The median follow-up period was 7.2 years. Follow-up was 97% complete.

RESULTS

Patient-prosthesis mismatch was present in 12% of the study population (n = 47). Ten-year freedom from reoperation for aortic bioprosthesis replacement was 74.3 ± 3.2%. During follow-up, 111 patients underwent reoperation for aortic bioprosthesis replacement. Causes of aortic bioprosthesis replacement were SVD of the bioprosthesis (n = 96), paravalvular leak (n = 10), and acute endocarditis (n = 5). According to unadjusted Kaplan-Meier analysis, patients with mismatch had a higher incidence of aortic bioprosthesis replacement for SVD when compared with patients without mismatch (log rank test: p 0.05). This result was confirmed by multivariable Cox regression analysis, which identified two independent predictors of aortic bioprosthesis replacement for SVD: patients' age (hazard ratio (HR) 0.967) and patient-prosthesis mismatch (HR 2.161).

CONCLUSION

Patients suffering from mismatch were twice as likely to undergo reoperation for aortic bioprosthesis replacement for SVD than those without mismatch.

摘要

目的

患者-人工瓣膜不匹配已被确定为主动脉瓣置换术后死亡以及接受生物人工主动脉瓣患者发生人工瓣膜结构退化(SVD)的危险因素。本研究的目的是比较存在不匹配的患者与不存在不匹配的人群中因SVD进行主动脉瓣生物人工瓣膜置换的发生率。

方法

回顾性分析了1974年至2009年期间接受生物人工瓣膜主动脉瓣置换的387例成年患者。如果预期的体表面积校正有效瓣口面积<0.70 cm²/m²,则认为存在不匹配。中位随访期为7.2年。随访完成率为97%。

结果

研究人群中12%(n = 47)存在患者-人工瓣膜不匹配。生物人工主动脉瓣置换术后10年免于再次手术的比例为74.3 ± 3.2%。随访期间,111例患者因生物人工主动脉瓣置换接受了再次手术。生物人工主动脉瓣置换的原因包括生物人工瓣膜的SVD(n = 96)、瓣周漏(n = 10)和急性心内膜炎(n = 5)。根据未校正的Kaplan-Meier分析,与不存在不匹配的患者相比,存在不匹配的患者因SVD进行生物人工主动脉瓣置换的发生率更高(对数秩检验:p < 0.05)。多变量Cox回归分析证实了这一结果,该分析确定了生物人工主动脉瓣置换治疗SVD的两个独立预测因素:患者年龄(风险比[HR] 0.967)和患者-人工瓣膜不匹配(HR 2.161)。

结论

存在不匹配的患者因SVD进行生物人工主动脉瓣置换再次手术的可能性是不存在不匹配患者的两倍。

相似文献

1
Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration.接受生物人工主动脉瓣植入的患者中,患者-人工瓣膜不匹配会增加因人工瓣膜结构退化而再次手术的风险。
J Card Surg. 2014 Jul;29(4):439-44. doi: 10.1111/jocs.12345. Epub 2014 Apr 29.
2
Twenty-year durability of the aortic Hancock II bioprosthesis in young patients: is it durable enough?年轻患者中主动脉 Hancock II 生物假体的 20 年耐久性:它足够耐用吗?
Eur J Cardiothorac Surg. 2014 Nov;46(5):825-30. doi: 10.1093/ejcts/ezu014. Epub 2014 Feb 7.
3
Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunction.超过 800 例患者的 Mitroflow 主动脉心包生物瓣的长期结果:耐久性有限和功能障碍的机制。
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):264-271. doi: 10.1093/ejcts/ezx161.
4
Influence of patient-prosthesis mismatch on long-term results after aortic valve replacement with a stented bioprosthesis.患者-人工瓣膜不匹配对带支架生物人工瓣膜主动脉瓣置换术后长期结果的影响。
J Heart Valve Dis. 2002 Jul;11(4):543-51.
5
Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.Mitroflow与Perimount心包生物瓣膜主动脉瓣置换术后的耐久性:2393例患者的单中心经验
Eur J Cardiothorac Surg. 2016 Jun;49(6):1705-10. doi: 10.1093/ejcts/ezv432. Epub 2016 Mar 16.
6
Influence of prosthesis-patient mismatch on diastolic heart failure after aortic valve replacement.人工瓣膜-患者不匹配对主动脉瓣置换术后舒张性心力衰竭的影响。
Ann Thorac Surg. 2008 Apr;85(4):1310-7. doi: 10.1016/j.athoracsur.2007.12.069.
7
Fate of aortic bioprostheses: An 18-year experience.主动脉生物假体的转归:18年的经验
J Thorac Cardiovasc Surg. 2016 Mar;151(3):754-761.e1. doi: 10.1016/j.jtcvs.2015.10.020. Epub 2015 Oct 23.
8
Early structural valve deterioration and reoperation associated with the mitroflow aortic valve.与Mitroflow主动脉瓣相关的早期结构性瓣膜退变及再次手术
J Card Surg. 2018 Dec;33(12):778-786. doi: 10.1111/jocs.13953. Epub 2018 Dec 7.
9
Mitroflow aortic pericardial bioprosthesis--clinical performance.Mitroflow 主动脉心包生物瓣——临床性能。
Eur J Cardiothorac Surg. 2009 Nov;36(5):818-24. doi: 10.1016/j.ejcts.2009.05.020. Epub 2009 Aug 22.
10
Further experience with the "no-react" bioprosthesis in patients with active infective endocarditis: 11-year single center results in 402 patients.“无反应”生物假体在活动性感染性心内膜炎患者中的进一步经验:402例患者的11年单中心研究结果
Thorac Cardiovasc Surg. 2013 Aug;61(5):398-408. doi: 10.1055/s-0033-1337903. Epub 2013 Apr 5.

引用本文的文献

1
Prosthesis-Patient Mismatch: Current State of Evidence.人工瓣膜-患者不匹配:证据现状
Curr Cardiol Rep. 2025 Feb 10;27(1):49. doi: 10.1007/s11886-025-02212-z.
2
Prosthesis-patient mismatch in transcatheter and surgical aortic valve replacement.经导管和外科主动脉瓣置换术中的人工瓣膜-患者不匹配
Ann Cardiothorac Surg. 2024 May 31;13(3):211-223. doi: 10.21037/acs-2023-aae-0166. Epub 2024 Apr 28.
3
Impact of Prosthesis-Patient Mismatch After Surgical Aortic Valve Replacement: Systematic Review and Meta-Analysis of Reconstructed Time-to-Event Data of 122 989 Patients With 592 952 Patient-Years.
人工主动脉瓣置换术后假体-患者不匹配的影响:122989 例患者 592952 患者年的重建时间事件数据的系统评价和荟萃分析。
J Am Heart Assoc. 2024 Apr 2;13(7):e033176. doi: 10.1161/JAHA.123.033176. Epub 2024 Mar 27.
4
Optimizing Valve Selection in Valve-in-Valve Transcatheter Aortic Valve Replacement: A Case Study on Addressing Patient-Prosthesis Mismatch and Early Structural Valve Deterioration in a Morbidly Obese Patient.经导管主动脉瓣置换术中瓣中瓣瓣膜选择的优化:解决病态肥胖患者人工瓣膜不匹配及早期人工瓣膜结构退化问题的病例研究
Cureus. 2024 Jan 29;16(1):e53191. doi: 10.7759/cureus.53191. eCollection 2024 Jan.
5
Two-Year Clinical Follow-Up Assessment of the Novel Cingular Surgical Bovine Pericardial Valve.新型带环牛心包瓣膜的两年临床随访评估
Front Cardiovasc Med. 2021 Dec 13;8:736877. doi: 10.3389/fcvm.2021.736877. eCollection 2021.
6
Transcatheter Aortic Valve-in-Valve Procedure in Patients with Bioprosthetic Structural Valve Deterioration.生物瓣结构性瓣膜衰败患者的经导管主动脉瓣中瓣手术
Methodist Debakey Cardiovasc J. 2017 Jul-Sep;13(3):132-141. doi: 10.14797/mdcj-13-3-132.
7
Prosthesis-Patient Mismatch After Aortic Valve Replacement.主动脉瓣置换术后人工瓣膜-患者不匹配
Curr Treat Options Cardiovasc Med. 2016 Nov;18(11):67. doi: 10.1007/s11936-016-0488-0.